Genesis Therapeutics rakes in $52m Series A
Genesis Therapeutics, a provider of AI technologies to create medicines for patients with severe and unmet medical needs, has raised $52 million in Series A financing.
Genesis Therapeutics, a provider of AI technologies to create medicines for patients with severe and unmet medical needs, has raised $52 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination